Skip to content

Cerus CERS Shares (Diluted)

Shares (Diluted) at other companies

Haemonetics logo
HaemoneticsHAE
47.4M-6.7%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
27M-3.6%
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
70.5M+12.0%
QuidelOrtho Corporation logo
QuidelOrtho CorporationQDEL
68.2M+1.0%
ADMA Biologics logo
ADMA BiologicsADMA
240M-1.9%
Paysign logo
PaysignPAYS
61M+10.7%

Other financials

Income statement

See full
Revenue$53.7M+24.1%
Operating income-$354.0K+94.0%
Net income-$1.6M+78.7%
EPS (diluted)-$0.01+75.0%

Balance sheet

See full
Cash & equivalents$27.9M+43.0%
Total debt$45.0M-43.3%
Total equity$67.6M+21.7%
Total assets$222.9M+7.8%

Cash flow

See full
Operating cash flow-$3.0M-261%
CapEx$233.0K+108%
Free cash flow-$3.3M-243%

Valuation

See full
Market cap$573.06M+124%
Enterprise value$590.17M+86.7%
P/S2.9×-1.0×

Profitability

See full
Gross margin64%
Operating margin-6.2%-2.1pp
Net margin-9.8%-2.8pp
FCF margin3.5%+1.9pp

Returns & leverage

See full
Return on equity-15.5%-5.6pp
Debt / equity0.7×-0.8×
Current ratio1.6×-0.7×

Where this comes from

Reported directly by Cerus in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The official record: Cerus’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cerus's shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cerus's shares (diluted)?
Cerus (CERS) reported shares (diluted) of 194.1M in Q1 2026.
How has Cerus's shares (diluted) changed year-over-year?
Cerus's shares (diluted) increased by 3.8% year-over-year, from 187.1M to 194.1M.
What is the long-term trend for Cerus's shares (diluted)?
Over 4 years (2021 to 2025), Cerus's shares (diluted) has grown at a 2.7% compound annual growth rate (CAGR), from 683.2M to 760.8M.
What does shares (diluted) mean?
The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.